Patents by Inventor Rosina Lopez-Alonso Fandiño

Rosina Lopez-Alonso Fandiño has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
    Patent number: 8227207
    Abstract: The invention relates to the production of ovoproducts containing bioactive peptides from the egg white subjected to enzymatic treatment. Said peptides have an inhibiting activity of the angiotensin converting enzyme (ACE inhibiting activity) in vitro and/or anti-hypertensive activity in rats and/or antioxidant activity. Said ovoproducts, complete hydrolyzates, the fractions thereof with low molecular weight or their constituent peptides could be used as therapeutic substances with ACE inhibiting activity and/or anti-hypertensive activity and/or anti-oxidant activity, either as functional food products, food additives or ingredients or pharmaceutical products for the treatment and/or prevention of hypertension in all its forms in humans or animals and for the treatment and/or prevention of any disorder associated with hypertension in humans or animals.
    Type: Grant
    Filed: January 30, 2006
    Date of Patent: July 24, 2012
    Assignee: Consejo Superior de Investigaciones Cientifcas
    Inventors: Marta Miguel Castro, Rosina Lopez-Alonso Fandiño, Maria Isidra Recio Sanchez, Maria Mercedes Ramos Gonzalez, Amaya Aleixandre De Artiñano
  • Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
    Publication number: 20060280804
    Abstract: The invention relates to the production of ovoproducts containing bioactive peptides from the egg white subjected to enzymatic treatment. Said peptides have an inhibiting activity of the angiotensin converting enzyme (ACE inhibiting activity) in vitro and/or anti-hypertensive activity in rats and/or antioxidant activity. Said ovoproducts, complete hydrolizates, the fractions thereof with low molecular weight or their constituent peptides could be used as therapeutic substances with ACE inhibiting activity and/or anti-hypertensive activity and/or anti-oxidant activity, either as functional food products, food additives or ingredients or pharmaceutical products for the treatment and/or prevention of hypertension in all its forms in humans or animals and for the treatment and/or prevention of any disorder associated with hypertension in humans or animals.
    Type: Application
    Filed: January 30, 2006
    Publication date: December 14, 2006
    Inventors: Marta Castro, Rosina Lopez-Alonso Fandino, Maria Recio Sanchez, Maria Ramos Gonzalez, Amaya Aleixandre De Artinano